[18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies

Flutemetamol F 18 injection PET images reflect brain beta-amyloid levels

(2012) Chris Buckley et al.   Alzheimers & Dementia

CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings

(2012) T. T. Seppala et al.   NEUROLOGY

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

(2011) Thomas J. Montine et al.   ACTA NEUROPATHOLOGICA

Association Between In Vivo Fluorine 18–Labeled Flutemetamol Amyloid Positron Emission Tomography Imaging and In Vivo Cerebral Cortical Histopathology

(2011) David A. Wolk   ARCHIVES OF NEUROLOGY

Amyloid PET imaging in patients with mild cognitive impairment: A 2-year follow-up study

(2011) J. Koivunen et al.   NEUROLOGY

Post-mortem findings in 10 patients with presumed normal-pressure hydrocephalus and review of the literature

(2011) V. Leinonen et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Technical aspects of amyloid imaging for Alzheimer's disease

(2011) Paul Edison et al.   Alzheimers Research & Therapy

The CERAD Neuropsychologic Battery Total Score and the Progression of Alzheimer Disease

(2010) Heidi C. Rossetti et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology

(2010) Roy Hamilton et al.   ANNALS OF NEUROLOGY

Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease

(2010) Ville Leinonen et al.   ANNALS OF NEUROLOGY

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial

(2010) Rik Vandenberghe et al.   ANNALS OF NEUROLOGY

11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

(2010) Juha O Rinne et al.   LANCET NEUROLOGY

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

(2010) Christopher C. Rowe et al.   NEUROBIOLOGY OF AGING

Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent — a pilot study

(2010) Kun-Ju Lin et al.   NUCLEAR MEDICINE AND BIOLOGY

Amyloid imaging in mild cognitive impairment subtypes

(2009) David A. Wolk et al.   ANNALS OF NEUROLOGY

Cognitive Decline and Brain Volume Loss as Signatures of Cerebral Amyloid-β Peptide Deposition Identified With Pittsburgh Compound B

(2009) Martha Storandt et al.   ARCHIVES OF NEUROLOGY

Update on amyloid imaging: From healthy aging to Alzheimer’s disease

(2009) David A. Wolk et al.   Current Neurology and Neuroscience Reports

Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease

(2009) N. Nelissen et al.   JOURNAL OF NUCLEAR MEDICINE

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

Biopsy Support for the Validity of Pittsburgh Compound B Positron Emission Tomography With a Twist

(2008) William E. Klunk   ARCHIVES OF NEUROLOGY

Assessment of β-Amyloid in a Frontal Cortical Brain Biopsy Specimen and by Positron Emission Tomography With Carbon 11–Labeled Pittsburgh Compound B

(2008) Ville Leinonen   ARCHIVES OF NEUROLOGY

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

(2008) Clifford R. Jack et al.   BRAIN

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

(2008) Milos D. Ikonomovic et al.   BRAIN

PET Amyloid Ligand [11C]PIB Uptake and Cerebrospinal Fluid β-Amyloid in Mild Cognitive Impairment

(2008) J. Koivunen et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B

(2008) Cyrus A. Raji et al.   JOURNAL OF NEUROSCIENCE METHODS

Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

(2008) Christopher C Rowe et al.   LANCET NEUROLOGY

PET imaging of amyloid deposition in patients with mild cognitive impairment

(2007) Anton Forsberg et al.   NEUROBIOLOGY OF AGING